
Vortioxetine eases depression in older adults, while cognitive gains stay mixed—showing selective boosts in attention and processing speed, not consistent global improvement.
There are a number of cognitive screening tools designed to help offer timely, quality care for the elderly and those struggling with cognitive loss and dementia.